Neurologic Consultants, PA

Fort Lauderdale, Florida 33308

0 studies enrolling now · 10 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Brain Infarction, Cerebral Ischemia, Idiopathic Parkinson's Disease, Stroke

Studies at this site

• A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke — Stopped early
• A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy — Completed
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist — Completed
• Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 — Completed
• Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa — Completed
• Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early